SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ambalal Sarabhai Enterprises informs about newspaper advertisements

14 Sep 2022 Evaluate

Pursuant to provisions of Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014 (as amended) and Regulations 30 and 47 of SEBI (LODR) Regulations, 2015, Ambalal Sarabhai Enterprises has informed that it enclosed a copy of newspaper advertisements published in Financial Express (English) & (Gujarati) giving public notice of 44th AGM of the Company to be held on Wednesday, September 21, 2022 at 11:00 am (IST) through Video Conferencing/ Other Audio Visual Means only and information relating to e-voting facility. The above information is also available on Company's website at www.ase.life.

The above information is a part of company’s filings submitted to BSE.

Ambalal Sarabhai Ent Share Price

31.87 0.54 (1.72%)
06-May-2026 14:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.00
Dr. Reddys Lab 1313.00
Cipla 1365.80
Zydus Lifesciences 938.80
Lupin 2449.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×